{
    "paper_id": "2d743c8bc9667a1c17e0fbfa63b10a085749c7a2",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "estimates of vaccine effectiveness in post-licensure settings. Further discussion of this topic by experts is warranted.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "A key feature common to all of these approval provisions is that the established standards for the demonstration of safety and effectiveness are maintained. From our perspective, if needed, any of these pathways to licensure could provide an alternative science-based approach to the demonstration of vaccine effectiveness against Ebola virus disease.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The rapid evolution of the Ebola outbreak will need continued regulatory flexibility and adjustment to approaches used for product development and approval. By fostering a high level of communication both together and with our stakeholders, the FDA, EMA, and Health Canada will continue to employ their science-based regulatory approaches to expedite Ebola vaccine licensure and thus facilitate the availability of one or more effective Ebola vaccines. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Code of Federal Regulations (CFR) title 21",
            "authors": [],
            "year": 2014,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Guidance document-submission and Information requirements for extraordinary use new drugs (EUNDs)",
            "authors": [],
            "year": 2014,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Immunology of protection from Ebola virus infection",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "R"
                    ],
                    "last": "Krause",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bryant",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Sci Transl Med",
            "volume": "7",
            "issn": "",
            "pages": "286--297",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Philip R Krause, Marco Cavaleri, Gina Coleman, Marion F Gruber Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA (PRK, MFG); Anti-infectives and Vaccines, European Medicines Agency, London, UK (MC); and Clinical Evaluation Division-Vaccines, Health Canada, Ottawa, ON, Canada (GC) philip.krause@fda.hhs.gov We declare no competing interests.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Comment www.thelancet.com/infection Vol 15 June 2015 629 Ministry of Health, Makkah, Saudi Arabia\" only. These corrections have been made to the online version as of May 19, 2015. Lauer KB, Faqih L, Blanchard TJ. Ebola: the real lessons from HIV scale-up. Lancet Infect Dis 2015; 15: 506-07-The title of this Correspondence should have been 'Long-term vaccine strategies for Ebola'. This correction has been made to the online version as of May 19, 2015.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}